<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>SLB &#8211; Stock Earnings</title>
	<atom:link href="https://cms.stocksearning.com/tag/slb/feed/" rel="self" type="application/rss+xml" />
	<link>https://cms.stocksearning.com</link>
	<description>Empowering Investors and Traders</description>
	<lastBuildDate>Wed, 29 Jul 2026 19:16:22 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.5</generator>

<image>
	<url>https://cms.stocksearning.com/wp-content/uploads/2025/10/cropped-cropped-SE_lovo_bimi-32x32.jpg</url>
	<title>SLB &#8211; Stock Earnings</title>
	<link>https://cms.stocksearning.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Morgan Stanley Says These 4 Quality Stocks Could Be Smart Buys Right Now</title>
		<link>https://cms.stocksearning.com/2026/07/morgan-stanley-4-stocks-smart-buys/</link>
					<comments>https://cms.stocksearning.com/2026/07/morgan-stanley-4-stocks-smart-buys/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Wed, 29 Jul 2026 19:15:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[GILD]]></category>
		<category><![CDATA[KO]]></category>
		<category><![CDATA[SLB]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=4779</guid>

					<description><![CDATA[Morgan Stanley's top dividend stock picks include Coca-Cola, Colgate-Palmolive, SLB, and Gilead Sciences. Here's why they're favored now.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Investors looking for the best dividend stocks and quality stocks to buy now may want to pay close attention to Morgan Stanley&#8217;s latest recommendations. As market volatility continues and economic uncertainty lingers, the Wall Street firm says companies with strong cash flow, healthy balance sheets, consistent earnings, and reliable dividends are well-positioned to outperform over the long run. Among Morgan Stanley&#8217;s top stock picks are four industry leaders spanning consumer staples, energy, and healthcare that could offer investors a combination of stability, income, and long-term growth potential.</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#coca-cola">Coca-Cola</a></li><li><a href="#colgate-palmolive">Colgate-Palmolive</a></li><li><a href="#slb">SLB</a></li><li><a href="#gilead-sciences">Gilead Sciences</a></li><li><a href="#bottom-line">Bottom Line For Morgan Stanley&#8217;s Top Picks</a></li></ul></nav></div>



<p class="wp-block-paragraph">Rather than chasing speculative growth names, Morgan Stanley believes investors may be better served by focusing on companies with durable business models that can generate dependable returns regardless of market conditions. These businesses tend to have strong pricing power, lower debt levels, healthy profit margins, and a history of rewarding shareholders through regular dividend payments.</p>



<p class="wp-block-paragraph">Here are four quality stocks Morgan Stanley likes at the moment.</p>



<h2 id="coca-cola" class="wp-block-heading">Coca-Cola</h2>



<p class="wp-block-paragraph"><a href="https://stocksearning.com/stocks/ko/earnings-date"><strong>Coca-Cola (NYSE: KO)</strong> </a>is one of Morgan Stanley&#8217;s favorite stocks.&nbsp;</p>



<p class="wp-block-paragraph">The company <a href="https://files.quartr.com/conference-calls/08f6155d2bc2d80cbb4f5f805eca835f-2026-07-28-11-00-14.pdf?ref=TWFya2V0QmVhdCBNZWRpYSBMTEM=" target="_blank" rel="noopener">recently reported better-than-expected earnings</a>. It also raised its outlook for the rest of the year. Investors liked the news, and the stock jumped more than 4%. And Morgan Stanley says Coca-Cola continues to grow because people keep buying its products. The company has also been able to raise prices without hurting sales. In addition, Coca-Cola pays a dividend with a yield of about 2.4%.</p>



<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="600" height="328" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/07/KO_2026-07-29_09-49-37-1-600x328.png" alt="morgan stanley-StockEarnings" class="wp-image-4806" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/07/KO_2026-07-29_09-49-37-1-600x328.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/07/KO_2026-07-29_09-49-37-1-300x164.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/07/KO_2026-07-29_09-49-37-1-768x420.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/07/KO_2026-07-29_09-49-37-1.png 1382w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 id="colgate-palmolive" class="wp-block-heading">Colgate-Palmolive</h2>



<p class="wp-block-paragraph"><strong><a href="https://stocksearning.com/stocks/cl/earnings-date">Colgate-Palmolive (NYSE: CL)</a></strong> is another company on Morgan Stanley&#8217;s list. The company makes everyday products like toothpaste, toothbrushes, soap, and other personal care items. These are products people buy no matter what the economy is doing. That helps make the company&#8217;s business more stable. Morgan Stanley believes Colgate-Palmolive still has room to grow even after a strong year. The company pays a dividend of about 2.3%.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="600" height="328" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/07/CL_2026-07-29_10-12-32-600x328.png" alt="morgan stanley-StockEarnings" class="wp-image-4805" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/07/CL_2026-07-29_10-12-32-600x328.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/07/CL_2026-07-29_10-12-32-300x164.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/07/CL_2026-07-29_10-12-32-768x420.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/07/CL_2026-07-29_10-12-32.png 1382w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 id="slb" class="wp-block-heading">SLB</h2>



<p class="wp-block-paragraph"><strong><a href="https://stocksearning.com/stocks/slb">SLB (NYSE: SLB)</a></strong> is an energy company that provides services to oil and gas producers. The company recently reported stronger-than-expected earnings and revenue. While some business slowed in the Middle East, strong demand in other parts of the world helped make up for it.</p>



<p class="wp-block-paragraph">Helping, SLB says offshore drilling and higher activity in the United States helped boost its results. The company pays a dividend with a yield of about 2.35%.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="600" height="328" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/07/SLB_2026-07-29_10-13-36-600x328.png" alt="morgan stanley-StockEarnings" class="wp-image-4807" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/07/SLB_2026-07-29_10-13-36-600x328.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/07/SLB_2026-07-29_10-13-36-300x164.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/07/SLB_2026-07-29_10-13-36-768x420.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/07/SLB_2026-07-29_10-13-36.png 1382w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 id="gilead-sciences" class="wp-block-heading">Gilead Sciences</h2>



<p class="wp-block-paragraph">Morgan Stanley says <strong><a href="https://stocksearning.com/stocks/gild/earnings-date">Gilead Sciences (NASDAQ: GILD)</a> </strong>could see strong sales from its HIV prevention drug called Yeztugo. The firm expects the drug to bring in about $1.1 billion in sales this year. That is slightly higher than what many Wall Street analysts expect. Gilead, expected to report earnings next week, also pays a dividend with a yield of about 2.4%.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="328" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/07/GILD_2026-07-29_10-13-51-600x328.png" alt="morgan stanley-StockEarnings" class="wp-image-4809" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/07/GILD_2026-07-29_10-13-51-600x328.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/07/GILD_2026-07-29_10-13-51-300x164.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/07/GILD_2026-07-29_10-13-51-768x420.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/07/GILD_2026-07-29_10-13-51.png 1382w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 id="bottom-line" class="wp-block-heading">Bottom Line For Morgan Stanley&#8217;s Top Picks </h2>



<p class="wp-block-paragraph">Morgan Stanley believes this is a good time to own strong, dependable companies instead of taking big risks on fast-growing stocks. The firm likes companies that have healthy finances, steady profits, and reliable cash flow. It also prefers businesses that pay regular dividends. </p>



<p class="wp-block-paragraph">Right now, Coca-Cola, Colgate-Palmolive, SLB, and Gilead Sciences are four of Morgan Stanley&#8217;s top picks. While the market may still have some bumps along the way, the firm believes these quality companies could continue to reward investors over the long term.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/07/morgan-stanley-4-stocks-smart-buys/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Halliburton Stock: Christmas in July for Patient Contrarians</title>
		<link>https://cms.stocksearning.com/2026/07/halliburton-stock-christmas-in-july/</link>
					<comments>https://cms.stocksearning.com/2026/07/halliburton-stock-christmas-in-july/#respond</comments>
		
		<dc:creator><![CDATA[Chris Markoch]]></dc:creator>
		<pubDate>Wed, 22 Jul 2026 13:45:00 +0000</pubDate>
				<category><![CDATA[Post-Earnings]]></category>
		<category><![CDATA[BKR]]></category>
		<category><![CDATA[HAL]]></category>
		<category><![CDATA[SLB]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=4298</guid>

					<description><![CDATA[Halliburton's selloff looks like traders overreacting to one soft data point. For contrarian-minded investors, this dip may be an early Christmas gift.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><strong><a href="https://stocksearning.com/stocks/HAL/earnings-date">Halliburton (NYSE: HAL)</a></strong> stock just did something that should make contrarian investors start looking for mistletoe, or at least some sleigh bells. Shares of the oilfield services giant fell 5.47% on July 21, closing at $33.19, even after the company beat expectations on both revenue and earnings. </p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#why-the-middle-east-headline-masks-a-stronger-story">Why the Middle East Headline Masks a Stronger Story</a></li><li><a href="#the-structural-demand-story-for-u-s-energy-isnt-going-away">The Structural Demand Story for U.S. Energy Isn&#8217;t Going Away</a></li><li><a href="#what-the-charts-say-about-halliburtons-next-move">What the Charts Say About Halliburton&#8217;s Next Move</a></li><li><a href="#what-could-go-wrong-with-this-thesis">What Could Go Wrong With This Thesis</a></li><li><a href="#the-bottom-line-for-halliburton-investors">The Bottom Line for Halliburton Investors</a></li></ul></nav></div>



<p class="wp-block-paragraph">That&#8217;s not a typo. Halliburton posted $5.7 billion in second-quarter revenue, up from $5.4 billion in Q1, with adjusted earnings of $0.55 per diluted share. Free cash flow came in at $668 million, and management returned roughly $200 million to shareholders through buybacks.</p>



<p class="wp-block-paragraph">So why the selloff? Investors zeroed in on one soft spot: Middle East/Asia revenue fell 2% sequentially to $1.3 billion, as the ongoing U.S.-Iran conflict disrupted activity in Kuwait, Iraq, and Qatar. That single data point overshadowed a much stronger overall picture, including a 7% sequential jump in North America revenue and broad-based international growth.</p>



<p class="wp-block-paragraph">This looks like a classic case of short-term traders punishing a stock for a narrow, headline-grabbing detail while ignoring the underlying trend. For long-term investors, that overreaction may have just created an attractive entry point. The structural case for Halliburton&#8217;s business, domestic drilling, infrastructure buildout, and energy demand tied to reshoring hasn&#8217;t changed. If anything, this quarter reinforced it. Below, I&#8217;ll walk through why the dip looks overdone, what the charts say, and where the bear case could still bite.</p>



<h2 id="why-the-middle-east-headline-masks-a-stronger-story" class="wp-block-heading">Why the Middle East Headline Masks a Stronger Story</h2>



<p class="wp-block-paragraph"><a href="https://files.quartr.com/reports/acd5da67c938ae1ed3a9f7c7b310099e-2026-07-21-10-49-40.pdf?ref=TWFya2V0QmVhdCBNZWRpYSBMTEM=" target="_blank" rel="noopener">Halliburton&#8217;s Q2 numbers</a> were, in aggregate, strong. Total revenue grew 6% sequentially, and operating income rose to $778 million, up from $679 million in Q1. The Completion and Production segment grew 6%, while Drilling and Evaluation grew 5%. Those aren&#8217;t the numbers of a company in distress.</p>



<p class="wp-block-paragraph">The Middle East softness is real, but it&#8217;s regional, not structural. Halliburton&#8217;s own release attributes the decline directly to &#8220;the ongoing geopolitical conflict in the Middle East,&#8221; naming Kuwait, Iraq, and Qatar specifically. That&#8217;s a geopolitical disruption, not a demand problem or a competitive loss.</p>



<p class="wp-block-paragraph">Meanwhile, North America revenue jumped 7% sequentially to $2.3 billion, which CEO Jeff Miller called an &#8220;encouraged&#8221; recovery with &#8220;incremental improvements through the year&#8221; expected. Europe/Africa/CIS revenue also grew 19% sequentially, driven by North Sea activity and new well construction in Namibia and Egypt.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="222" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_Earnings-002-600x222.png" alt="Halliburton - StockEarnings" class="wp-image-4301" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_Earnings-002-600x222.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_Earnings-002-300x111.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_Earnings-002-768x284.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_Earnings-002.png 1137w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<p class="wp-block-paragraph">Markets often punish the one bad number in an otherwise solid report. That&#8217;s arguably what happened here. Investors who can look past a single regional disruption may be getting Halliburton at a discount.</p>



<h2 id="the-structural-demand-story-for-u-s-energy-isnt-going-away" class="wp-block-heading">The<strong> </strong>Structural Demand Story for U.S. Energy Isn&#8217;t Going Away</h2>



<p class="wp-block-paragraph">The conventional wisdom says oil prices will crater once the U.S.-Iran conflict ends. Two things complicate that narrative. First, there&#8217;s no clear end date in sight; the conflict has proven more durable than many expected.</p>



<p class="wp-block-paragraph">Second, and more important, is what happens to U.S. energy demand regardless of geopolitics. AI data centers get most of the attention, but they&#8217;re only part of the story. Roads, bridges, and grid upgrades all require energy-intensive materials and construction. Add in the billions of dollars companies are committing to reshoring manufacturing onto U.S. soil, and the demand backdrop for oil and gas looks durable, not fragile.</p>



<p class="wp-block-paragraph">Halliburton doesn&#8217;t need $100 oil to thrive. It needs producers to keep drilling. As long as North America activity keeps recovering, as this quarter suggests it is, the company&#8217;s core business should hold up. Rivals like <strong><a href="https://stocksearning.com/stocks/SLB/earnings-date">SLB (NYSE: SLB)</a></strong> and <strong><a href="https://stocksearning.com/stocks/BKR">Baker Hughes (NASDAQ: BKR)</a></strong> face a similar setup.</p>



<h2 id="what-the-charts-say-about-halliburtons-next-move" class="wp-block-heading">What the Charts Say About Halliburton&#8217;s Next Move</h2>



<p class="wp-block-paragraph">Halliburton&#8217;s chart shows a stock in a clear downtrend since its May 2026 high near $43, now trading below both its 50-day ($37.69) and 200-day ($33.39) moving averages. Tuesday&#8217;s post-earnings drop pushed shares to $33.19, right at the 200-day line, an important technical level.</p>



<p class="wp-block-paragraph">That line has acted as support before, most notably during the September-October 2025 base-building period. A decisive close below $33 on heavy volume, and Tuesday&#8217;s 33.75 million shares traded were well above average, would be a bearish signal worth watching. But if support holds here, the setup favors a stabilization attempt rather than a deeper breakdown. Watch this level closely over the next several sessions.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_2026-07-21_16-38-22-600x312.png" alt="halliburton - StockEarnings" class="wp-image-4302" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_2026-07-21_16-38-22-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_2026-07-21_16-38-22-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_2026-07-21_16-38-22-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/07/HAL_2026-07-21_16-38-22.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 id="what-could-go-wrong-with-this-thesis" class="wp-block-heading">What Could Go Wrong With This Thesis</h2>



<p class="wp-block-paragraph">No bull case is complete without acknowledging the risks. The most obvious: if the U.S. targets Iranian oil infrastructure directly, or if Iran and its proxies retaliate against energy infrastructure elsewhere, Halliburton&#8217;s &#8220;muddy&#8221; Middle East picture could turn into something worse. Regional disruption could spread beyond Kuwait, Iraq, and Qatar.</p>



<p class="wp-block-paragraph">There&#8217;s also a demand-side risk that cuts in the opposite direction. If the conflict resolves and OPEC+ supply returns to the market faster than expected, the U.S. could find itself oversupplied. That would be good news for consumers at the pump, but bad news for oilfield services companies like Halliburton, which depend on producers maintaining active drilling programs.</p>



<p class="wp-block-paragraph">Neither scenario is playing out yet. Q2 results showed North America recovering, not retreating. But investors should recognize that both a Middle East escalation and a global oversupply scenario are live possibilities, and either could pressure the stock further before this thesis plays out.</p>



<h2 id="the-bottom-line-for-halliburton-investors" class="wp-block-heading">The Bottom Line for Halliburton Investors</h2>



<p class="wp-block-paragraph">Halliburton&#8217;s selloff looks like a case of traders overreacting to one soft data point in an otherwise strong quarter. The company beat on revenue, grew operating income, and generated healthy free cash flow, all while returning capital to shareholders through buybacks and dividends.</p>



<p class="wp-block-paragraph">The bear case isn&#8217;t imaginary. Escalation risk in the Middle East and a potential oversupply scenario are both real. But neither is likely to show up in the numbers for at least the next two quarters. Until then, Halliburton&#8217;s core North American recovery and structural U.S. energy demand story remains intact.</p>



<p class="wp-block-paragraph">For long-term, contrarian-minded investors, this dip may be less a warning sign and more an early Christmas gift.</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/07/halliburton-stock-christmas-in-july/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
